| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/06/2004 | US6673548 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/06/2004 | US6673547 Apparatus for use in the detection and analysis of nucleotide sequence polymorphisms |
| 01/06/2004 | US6673546 Genetic map of aging resistance gene; for use in prevention or delay of cardiovascular disease, stroke, alzheimer's disease, cancer and vision defects |
| 01/06/2004 | US6673545 Nucleotide sequences for use in the detection and treatment of prostate cancer |
| 01/06/2004 | US6673542 Assays for measuring nucleic acid damaging activities |
| 01/06/2004 | US6673541 DNA amplification of a single cell |
| 01/06/2004 | US6673540 Cell systems having specific interaction of peptide binding pairs |
| 01/06/2004 | US6673538 Methods and compositions for designing vaccines |
| 01/06/2004 | US6673536 Methods of ranking oligonucleotides for specificity using wash dissociation histories |
| 01/06/2004 | US6673534 Methods for detection of mutations in myostatin variants |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673343 Useful for activating their respective receptor and thereby enabling the role of tyrosine kinase receptor in cell growth and/or differentiation to be studied |
| 01/06/2004 | US6673222 Biological activity probe |
| 01/06/2004 | US6673024 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 01/06/2004 | US6672458 Efficient separation |
| 01/06/2004 | CA2281709C Detection of microbial metabolites |
| 01/06/2004 | CA2096109C Tissue factor based prothrombin time reagent |
| 01/02/2004 | EP1376136A2 Assay for the determination of the hormonal effect of compounds |
| 01/02/2004 | EP1376133A1 Method of screening prediabetic state and screening reagent |
| 01/02/2004 | EP1376128A1 Method and apparatus for impedimetric detection of one or more analytes in a sample |
| 01/02/2004 | EP1376126A1 Electrophoresis |
| 01/02/2004 | EP1376125A1 Radiolabeled photosensitisers for use in cancer screening |
| 01/02/2004 | EP1376111A1 Method and device for high sensitivity detection of the presence of DNA and other probes |
| 01/02/2004 | EP1375677A1 Probes for detecting and identifying helicobacter pylori |
| 01/02/2004 | EP1375676A2 Methods of synthesizing polynucleotides by ligation of multiple oligomers |
| 01/02/2004 | EP1375674A1 Method of detecting nucleic acids using probes with fluorescent labels by analysis of the fluorescence melting curves |
| 01/02/2004 | EP1375673A1 Gene analysis method and analyzer therefor |
| 01/02/2004 | EP1375672A1 Method of detecting nucleic acid relating to disease |
| 01/02/2004 | EP1375666A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof |
| 01/02/2004 | EP1375660A1 Method of isolating nucleic acid |
| 01/02/2004 | EP1375657A1 Gene panel participating in liver regeneration |
| 01/02/2004 | EP1375648A1 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375510A1 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions |
| 01/02/2004 | EP1374997A1 Instrument and method for collecting nucleic acids |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1374827A2 Method for preparing stabilised reaction mixtures, which are totally or partially dried, comprising at least one enzyme, reaction mixtures and kits containing said mixtures |
| 01/02/2004 | EP1374681A1 Process for identifying fungicidally active compounds |
| 01/02/2004 | EP1374134A2 Method and system for identifying commercially distributed organisms |
| 01/02/2004 | EP1373906A1 Method for diagnosing chronic intestinal inflammatory diseases |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373902A1 No synthase assay particles and method |
| 01/02/2004 | EP1373898A2 Detection of inflammations |
| 01/02/2004 | EP1373897A1 Recovery of enzyme activity from enveloped viruses |
| 01/02/2004 | EP1373896A2 Cell-based detection and differentiation of disease states |
| 01/02/2004 | EP1373894A1 Microcavity biosensor, methods of making, and uses thereof |
| 01/02/2004 | EP1373893A2 Phosphoprotein target for insulin and its antagonists |
| 01/02/2004 | EP1373889A2 Biosensors, reagents and diagnostic applications of directed evolution |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373885A2 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism |
| 01/02/2004 | EP1373876A1 Distinguishing test types through spectral analysis |
| 01/02/2004 | EP1373871A2 Determination of analytes by means of fluorescence correlation spectroscopy |
| 01/02/2004 | EP1373870A1 Device for referencing fluorescence signals |
| 01/02/2004 | EP1373868A1 Improved affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| 01/02/2004 | EP1373857A2 Examination device and method for examination of chemical and/or biological samples |
| 01/02/2004 | EP1373855A2 Identification and enumeration of coccidial sporocysts |
| 01/02/2004 | EP1373577A1 Fluorescent polymer superquenching-based bioassays |
| 01/02/2004 | EP1373576A2 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates |
| 01/02/2004 | EP1373575A2 Methods for detection of human papillomavirus mrna |
| 01/02/2004 | EP1373574A2 P450 single nucleotide polymorphism biochip analysis |
| 01/02/2004 | EP1373573A2 Conjugate probes and optical detection of analytes |
| 01/02/2004 | EP1373571A2 Functional surface display of polypeptides |
| 01/02/2004 | EP1373569A1 Pcr method |
| 01/02/2004 | EP1373568A2 Gene for identifying individuals with familial dysautonomia |
| 01/02/2004 | EP1373567A2 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 01/02/2004 | EP1373566A2 Polynucleotide analysis using combinatorial pcr |
| 01/02/2004 | EP1373565A2 Methods for the diagnosis and treatment of tumors employing the hepsin gene |
| 01/02/2004 | EP1373564A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 01/02/2004 | EP1373563A2 Method for detecting micro-organisms |
| 01/02/2004 | EP1373562A2 Method for determining whether a test compound binds to a large rna target |
| 01/02/2004 | EP1373561A2 Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing |
| 01/02/2004 | EP1373560A1 Oligonucleotide primers for the phosphatidylinositol specific phospholipase c gene and method for the detection of bacillus cereus |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373558A1 Universal primers for wildlife identification |
| 01/02/2004 | EP1373557A2 Use of generic oligonucleotide microchips to detect protein-nucleic acid interactions |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373553A2 Method for extracting intact micro-organisms from sludge or biofilms |
| 01/02/2004 | EP1373552A2 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 01/02/2004 | EP1373551A2 Multiple determinants for metabolic phenotypes |
| 01/02/2004 | EP1373531A1 Method of encoding information in nucleic acids of a genetically engineered organism |
| 01/02/2004 | EP1373529A1 Tau-opathy model |
| 01/02/2004 | EP1373528A1 Novel expression vectors |
| 01/02/2004 | EP1373520A2 Motor proteins and methods for their use |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373481A1 Methods of screening for introduction of dna into a target cell |
| 01/02/2004 | EP1373479A1 Methods for monitoring prothease inhibitor antiretroviral therapy |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373472A1 Methods and gel compositions for encapsulating living cells and organic molecules |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373469A2 Ab initio physics-based gene identification method |
| 01/02/2004 | EP1373467A1 Device and method for detection of multiple analytes |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |